Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FCER2 | P06734 | 5/20 | 0.60 |
| ▸ | MMP1 | P03956 | 4/20 | 0.60 |
| ▸ | MME | P08473 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP3 | P08254 | 1/20 | 0.55 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.54 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.54 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | REN | P00797 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24084025 | 0.90 | MME (0.60) | FCER2MMP1MMECYP3A4MAPK1 | |
| SCHEMBL27354283 | 0.89 | FCER2 (0.67) | FCER2MMP1MMEMMP2MMP3 | |
| SCHEMBL9556647 | 0.89 | FCER2 (0.67) | FCER2MMP1MMEERAP2ERAP1 | |
| SCHEMBL15223611 | 0.88 | MME (0.74) | MMECYP3A4MAPK1MMP2LTA4H | |
| SCHEMBL12057953 | 0.87 | LTA4H (0.62) | FCER2MMP1MMEMMP2MMP3 | |
| SCHEMBL31185441 | 0.87 | LTA4H (0.62) | FCER2MMP1MMEMMP2MMP3 | |
| SCHEMBL12038997 | 0.87 | LTA4H (0.62) | FCER2MMP1MMEMMP2MMP3 | |
| SCHEMBL2487473 | 0.87 | LTA4H (0.62) | FCER2MMP1MMEMMP2MMP3 | |
| SCHEMBL30626017 | 0.87 | LTA4H (0.62) | FCER2MMP1MMEMMP2MMP3 | |
| SCHEMBL7302253 | 0.86 | FCER2 (0.61) | FCER2MMP1MMEMMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11813334-B2 | Polyethylene glycol conjugate drug, and preparation method therefor and use thereof | Chongqing Upgra Biotechnology Co., Ltd. (CN) | 2023-11-14 | — | — | US | disclosed |
| US-11793881-B2 | Polyethylene glycol conjugate medicament, preparation method therefor and use thereof | Chongqing Upgra Biotechnology Co., Ltd. (CN) | 2023-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793881-B2 | Polyethylene glycol conjugate medicament, preparation method therefor and use thereof | SLC10A1, SLC10A2, NOTUM | FCER2 874/4885MMP1 2275/4885MME 91/4885 |
| US-11813334-B2 | Polyethylene glycol conjugate drug, and preparation method therefor and use thereof | FAR1, SLC10A1, THEM6 | FCER2 1361/4885MMP1 3225/4885MME 491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.